Prognosticating metastatic osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate and delayed metastasectomy: a single center experience of 102 patients

被引：0
|
作者：
V. Nataraj
S. Rastogi
S. A. Khan
M. C. Sharma
S. Agarwala
S. Vishnubhatla
S. Bakhshi
机构：
[1] Dr. B.R.A Institute Rotary Cancer Hospital,Department of Medical Oncology
[2] All India Institute of Medical Sciences,Department of Orthopedics
[3] All India Institute of Medical Sciences,Department of Pathology
[4] All India Institute of Medical Sciences,Department of Pediatric Surgery
[5] All India Institute of Medical Sciences,Department of Biostatistics
[6] All India Institute of Medical Sciences,undefined
来源：
Clinical and Translational Oncology | 2016年 / 18卷
关键词：
Delayed metastasectomy; Metastatic osteosarcoma; Without high dose methotrexate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：937 / 944
页数：7
相关论文
共 50 条
  • [21] Outcome and Clinical Predictors of Pediatric Lymphoblastic Lymphoma Treated with a Uniform Protocol: A Single Center Experience of 65 Patients from India
    Patel, A.
    Sharma, M. C.
    Sreenivas, V.
    Bakhshi, S.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S209 - S209
  • [22] PRIMARY CHEMOTHERAPY AND DELAYED SURGERY FOR NONMETASTATIC OSTEOSARCOMA OF THE EXTREMITIES - RESULTS IN 164 PATIENTS PREOPERATIVELY TREATED WITH HIGH-DOSES OF METHOTREXATE FOLLOWED BY CISPLATIN AND DOXORUBICIN
    BACCI, G
    PICCI, P
    FERRARI, S
    RUGGIERI, P
    CASADEI, R
    TIENGHI, A
    DELPREVER, AB
    GHERLINZONI, F
    MERCURI, M
    MONTI, C
    CANCER, 1993, 72 (11) : 3227 - 3238
  • [23] Non- High Dose -Methotrexate (HD-MTX) Based, Dose-Dense (DD), Combination, Chemotherapy(CT) in 83 Metastatic Osteosarcoma Patients: A Tertiary Care Centre Experience from India
    Bajpai, J.
    Talreja, V.
    Karpe, A.
    Vora, T.
    Rekhi, B.
    Gupta, S.
    Banavali, S.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S121 - S121
  • [24] AGE AND SUBSEQUENT CYCLES ARE ASSOCIATED WITH HIGH INCIDENCE OF METHOTREXATE DELAYED EXCRETION IN PEDIATRIC OSTEOSARCOMA PATIENTS. AN EXPERIENCE FROM A SINGLE INSTITUTION IN JORDAN
    Ismael, T.
    Sultan, I.
    Halalshah, H.
    Al-Jumaily, U.
    Omar, S.
    Amireh, A.
    Nazer, L.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 88 - 88
  • [25] Clinical predictors of severe toxicity in patients treated with combination chemotherapy with irinotecan and/or oxaliplatin for metastatic colorectal cancerA single center experience
    Roberto Díaz
    Jorge Aparicio
    Jorge Molina
    Laura Palomar
    Alejandra Giménez
    José Ponce
    Ángel Segura
    José Gómez-Codina
    Medical Oncology, 2006, 23 : 347 - 357
  • [26] Prevention of oral mucositis with palifermin in patients treated with high-dose chemotherapy and autologous stem cell transplantation. A single center experience.
    Luthi, Francois
    Berwert, Lorenzo
    Frossard, Valerie
    Marchetti, Oscar
    Rosselet, Anne
    Duchosal, Michel
    Ketterer, Nicolas
    BLOOD, 2006, 108 (11) : 843A - 843A
  • [27] Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: Study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatin
    Bacci, G
    Ferrari, S
    Delepine, N
    Bertoni, F
    Picci, P
    Mercuri, M
    Bacchini, P
    del Prever, AB
    Tienghi, A
    Comandone, A
    Campanacci, M
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) : 658 - 663
  • [28] TANDEM HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL RESCUE IN HIGH RISK NEUROBLASTOMA PATIENTS: A SINGLE CENTER EXPERIENCE
    Kim, S. J.
    Kim, H.
    Lee, J. W.
    Park, K. D.
    Shin, H. Y.
    Ahn, H. S.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S374 - S374
  • [29] TANDEM HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL RESCUE IN HIGH RISK NEUROBLASTOMA PATIENTS: A SINGLE CENTER EXPERIENCE
    Ahn, H. S.
    Kim, S.
    Lee, J. W.
    Kang, H. J.
    Park, K. D.
    Yoo, E. S.
    Ryu, K. H.
    Kim, H. Y.
    Park, K. W.
    Lee, K. S.
    Choi, Y. M.
    Shin, H. Y.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 111 - 111
  • [30] High dose chemotherapy (HDCT) in 53 patients with locally advanced or metastatic breast cancer - A single institution experience.
    Anhuf, J
    Dreier, N
    Rueger, I
    Eberhardt, B
    Westerhausen, M
    BONE MARROW TRANSPLANTATION, 1999, 23 : S39 - S39
12345